AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
-15.75%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$1.72B
AUM Growth
+$1.72B
(-12%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
13.51%
Top 10 Holdings %
Top 10 Hldgs %
74.83%
Holding
51
New
2
Increased
2
Reduced
5
Closed
–
Top Buys
| 1 |
Prime Medicine
PRME
|
$247M |
| 2 |
CrowdStrike
CRWD
|
$65.5M |
| 3 |
GitLab
GTLB
|
$31.9M |
| 4 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$302K |
Top Sells
| 1 |
DexCom
DXCM
|
$84.9M |
| 2 |
Lyft
LYFT
|
$9.7M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$8.22M |
| 4 |
VLD
Velo3D, Inc.
VLD
|
$7.75M |
| 5 |
Rani Therapeutics
RANI
|
$1.21M |
Sector Composition
| 1 | Healthcare | 54.09% |
| 2 | Technology | 31.93% |
| 3 | Industrials | 9% |
| 4 | Financials | 2.36% |
| 5 | Consumer Staples | 2.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Prime Medicine
PRME
$578M
| $247M | 14.34% | +13,284,688 | New | +$247M |
|
|
VERV
2
DELISTED
Verve Therapeutics
VERV
| $204M | 11.86% | 10,549,086 -424,925 | -4% | -$8.22M |
|
3
UiPath
PATH
$5.95B
| $179M | 10.39% | 14,068,674 | – | – |
|
|
4
DexCom
DXCM
$29.5B
| $142M | 8.22% | 1,250,000 -750,000 | -38% | -$84.9M |
|
5
Planet Labs
PL
$2.15B
| $139M | 8.07% | 31,942,641 | – | – |
|
|
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
| $117M | 6.81% | 47,675,476 +122,789 | +0.3% | +$302K |
|
7
Snowflake
SNOW
$79.6B
| $76.9M | 4.47% | 535,604 | – | – |
|
|
8
CrowdStrike
CRWD
$106B
| $65.5M | 3.8% | +622,073 | New | +$65.5M |
|
9
Freshworks
FRSH
$3.93B
| $59.4M | 3.45% | 4,035,595 | – | – |
|
10
Oscar Health
OSCR
$4.31B
| $59.1M | 3.44% | 24,042,864 | – | – |
|
|
11
GitLab
GTLB
$7.93B
| $58.8M | 3.42% | 1,294,527 +701,123 | +118% | +$31.9M |
|
|
12
Lyft
LYFT
$6.73B
| $57.9M | 3.37% | 5,257,563 -880,591 | -14% | -$9.7M |
|
13
Duolingo
DUOL
$13.6B
| $50.1M | 2.91% | 704,444 | – | – |
|
14
Robinhood
HOOD
$92.4B
| $40.1M | 2.33% | 4,928,535 | – | – |
|
|
BHIL
15
DELISTED
Benson Hill, Inc.
BHIL
| $39.7M | 2.3% | 15,352,271 | – | – |
|
16
Relay Therapeutics
RLAY
$619M
| $23.4M | 1.36% | 1,568,753 | – | – |
|
17
Lyell Immunopharma
LYEL
$213M
| $20.4M | 1.18% | 5,865,125 | – | – |
|
|
DM
18
DELISTED
Desktop Metal, Inc.
DM
| $15M | 0.87% | 11,048,730 | – | – |
|
|
ME
19
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $14.6M | 0.85% | 6,736,785 | – | – |
|
20
Beam Therapeutics
BEAM
$1.66B
| $12.6M | 0.73% | 321,604 | – | – |
|
21
Monte Rosa Therapeutics
GLUE
$296M
| $11.1M | 0.65% | 1,464,015 | – | – |
|
22
Sana Biotechnology
SANA
$777M
| $11.1M | 0.65% | 2,812,500 | – | – |
|
23
Illumina
ILMN
$15.8B
| $10.8M | 0.63% | 53,470 | – | – |
|
24
RAPT Therapeutics
RAPT
$188M
| $10.7M | 0.62% | 540,270 | – | – |
|
25
Invivyd
IVVD
$204M
| $8.52M | 0.49% | 5,680,785 | – | – |
|